title: Prediction of AVM obliteration after stereotactic radiotherapy using radiobiological modelling.
abstract: This study was carried out in order to derive the radiobiological parameters of the dose-response relation for the obliteration of arteriovenous malformation (AVM) following single fraction stereotactic radiotherapy. Furthermore, the accuracy by which the linear Poisson model predicts the probability of obliteration and how the haemorrhage history, location and volume of the AVM influence its radiosensitivity are investigated. The study patient material consists of 85 patients who received radiation for AVM therapy. Radiation-induced AVM obliterations were assessed on the basis of post-irradiation angiographies and other radiological findings. For each patient the dose delivered to the clinical target volume and the clinical treatment outcome were available. These data were used in a maximum likelihood analysis to calculate the best estimates of the parameters of the linear Poisson model. The uncertainties of these parameters were also calculated and their individual influence on the dose-response curve was studied. AVM radiosensitivity was assumed to be the same for all the patients. The radiobiological model used was proved suitable for predicting the treatment outcome pattern of the studied patient material. The radiobiological parameters of the model were calculated for different AVM locations, bleeding histories and AVM sizes. The range of parameter variability had considerable effect on the dose-response curve of AVM. The correlation between the dosimetric data and their corresponding clinical effect could be accurately modelled using the linear Poisson model. The derived response parameters can be introduced into the clinical routine with the calculated accuracy assuming the same methodology in target definition and delineation. The known volume dependence of AVM radiosensitivity was confirmed. Moreover, a trend relating AVM location with its radiosensitivity was observed.
authors.affiliation: Department of Medical Radiation Physics, Karolinska Institutet and Stockholm University, Sweden. takis@radfys.ks.se
authors.forename: Panayiotis
authors.initials: P
authors.lastname: Mavroidis
authors.forename: Kyriaki
authors.initials: K
authors.lastname: Theodorou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Lefkopoulos
authors.forename: François
authors.initials: F
authors.lastname: Nataf
authors.forename: Michel
authors.initials: M
authors.lastname: Schlienger
authors.forename: Bengt
authors.initials: B
authors.lastname: Karlsson
authors.forename: Ingmar
authors.initials: I
authors.lastname: Lax
authors.forename: Constantin
authors.initials: C
authors.lastname: Kappas
authors.forename: Bengt K
authors.initials: BK
authors.lastname: Lind
authors.forename: Anders
authors.initials: A
authors.lastname: Brahme
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002536:Cerebral Arteries / Q000002:abnormalities / Q000601:surgery; D002550:Cerebral Veins / Q000002:abnormalities / Q000601:surgery; D002648:Child; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D008955:Models, Cardiovascular; D015233:Models, Statistical; D016634:Radiosurgery / Q000379:methods*; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D012189:Retrospective Studies; D016896:Treatment Outcome